Epax to invest $35 million in Omega-3
Epax is investing $35 million over the next two years to increase its capacity and boost innovation in the Omega-3 sector.
The marine oil manufacturing company will expand capacity at its main production facility in Ålesund in Norway, allowing output to increase by more than 50% by 2021. Meanwhile, a new manufacturing facility nearby will provide raw materials for new and specialised marine ingredients.
The investment will also allow the implementation of new technology to increase EPA and DHA concentration without triggering oxidation. The new distillation process will pave the way for gently processed products with concentration as high as 70% percentage by weight (compared to the current industry standard of 50wt%).
Bjørn Refsum, CEO of Epax, said: “We’re particularly excited about our new distillation process, which we believe is the most effective and environmentally friendly way to achieve high levels of EPA and DHA without creating unwanted by-products and waste materials.”
At this year’s SupplySide West (17th-18th October in Las Vegas) the company will showcase products including:
-
EPAX 0460 TGN and EPAX 1500 TGN: High-DHA products ideal for prenatal and postnatal health, children’s health and healthy aging
-
EPAX 5025 TGN: A high Omega-3 product typically used in formulations targeting healthy inflammatory response and sports nutrition
All three products are certified sustainable and responsibly sourced by Friend of the Sea (FOS) and IFFO, the Marine Ingredients Organisation. They are also certified Halal.